Editorial
doi: 10.1002/hep.26959.
Epub 2014 Feb 28.
Type I and type III interferon-induced immune response: it's a matter of kinetics and magnitude
Affiliations
- PMID: 24677190
- DOI: 10.1002/hep.26959
Item in Clipboard
Editorial
Type I and type III interferon-induced immune response: it's a matter of kinetics and magnitude
Hepatology.
2014 Apr.
No abstract available
Comment on
-
Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus.Hepatology. 2014 Apr;59(4):1250-61. doi: 10.1002/hep.26653. Epub 2014 Feb 14. Hepatology. 2014. PMID: 23913866 Free PMC article.
-
Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression.Hepatology. 2014 Apr;59(4):1262-72. doi: 10.1002/hep.26657. Epub 2014 Feb 18. Hepatology. 2014. PMID: 23929627 Free PMC article.
Similar articles
-
Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.PLoS One. 2015 Jul 20;10(7):e0133800. doi: 10.1371/journal.pone.0133800. eCollection 2015. PLoS One. 2015. PMID: 26193702 Free PMC article.
-
Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus.Hepatology. 2014 Apr;59(4):1250-61. doi: 10.1002/hep.26653. Epub 2014 Feb 14. Hepatology. 2014. PMID: 23913866 Free PMC article.
-
Incidence of hepatocellular carcinoma and response to interferon therapy in HCV-infected patients: effect of factors associated with the therapeutic response and incidence of HCC.Liver Int. 2012 Jul;32(6):1029-31. doi: 10.1111/j.1478-3231.2012.02763.x. Epub 2012 Feb 8. Liver Int. 2012. PMID: 22314231 No abstract available.
-
[Hepatitis virus and hepatocellular carcinoma].Gastroenterol Clin Biol. 1999 Mar;23(3):363-75. Gastroenterol Clin Biol. 1999. PMID: 10384341 Review. French. No abstract available.
-
The interaction of alcoholic liver disease and hepatitis C.Hepatogastroenterology. 1998 Mar-Apr;45(20):331-9. Hepatogastroenterology. 1998. PMID: 9638402 Review.
Cited by
-
Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees.World J Hepatol. 2015 Jan 27;7(1):53-69. doi: 10.4254/wjh.v7.i1.53. World J Hepatol. 2015. PMID: 25624997 Free PMC article. Review.
-
Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut.Front Immunol. 2017 Apr 21;8:459. doi: 10.3389/fimmu.2017.00459. eCollection 2017. Front Immunol. 2017. PMID: 28484457 Free PMC article.
-
Protective immunity against hepatitis C: many shades of gray.Front Immunol. 2014 Jun 16;5:274. doi: 10.3389/fimmu.2014.00274. eCollection 2014. Front Immunol. 2014. PMID: 24982656 Free PMC article. Review.
-
Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.PLoS One. 2015 Jul 20;10(7):e0133800. doi: 10.1371/journal.pone.0133800. eCollection 2015. PLoS One. 2015. PMID: 26193702 Free PMC article.
-
IFN-λ: A New Class of Interferon with Distinct Functions-Implications for Hepatitis C Virus Research.Gastroenterol Res Pract. 2015;2015:796461. doi: 10.1155/2015/796461. Epub 2015 May 20. Gastroenterol Res Pract. 2015. PMID: 26078754 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical